--- title: "The controlling shareholder of Jiangxi Hungpai New Material plans to reduce its holdings by no more than 3%" type: "News" locale: "en" url: "https://longbridge.com/en/news/256732259.md" description: "According to the announcement from Hongpai New Material, due to the funding needs of its shareholders, the controlling shareholder Hongpai Chemical plans to reduce its holdings in the company by no more than 19.5 million shares, accounting for no more than 3% of the company's total share capital as of September 9, 2025. The reduction period will be within 3 months starting from 15 trading days after the disclosure of this reduction plan" datetime: "2025-09-10T11:32:11.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/256732259.md) - [en](https://longbridge.com/en/news/256732259.md) - [zh-HK](https://longbridge.com/zh-HK/news/256732259.md) --- # The controlling shareholder of Jiangxi Hungpai New Material plans to reduce its holdings by no more than 3% According to the announcement from Hongpai New Material (605366.SH), due to the funding needs of its shareholders, the controlling shareholder Hongpai Chemical plans to reduce its holdings in the company by no more than 19.5 million shares, which does not exceed 3% of the company's total share capital as of September 9, 2025. The reduction period will be within three months starting from 15 trading days after the disclosure of this reduction plan ### Related Stocks - [605366.CN](https://longbridge.com/en/quote/605366.CN.md) ## Related News & Research - [CMOC Group (CMCLF): New Buy Recommendation for This Basic Materials Giant](https://longbridge.com/en/news/286625840.md) - [PTA-DD: Warimpex Finanz- und Beteiligungs AG: Managers' transactions announcement according to article 19 MAR](https://longbridge.com/en/news/286901864.md) - [Valhalla Metals Announces Closing of First Tranche of Over-Subscribed Private Placement | VMXXF Stock News](https://longbridge.com/en/news/286904505.md) - [Express Wash Concepts Opens 13th Greater Pittsburgh Clean Express Auto Wash](https://longbridge.com/en/news/287067902.md) - [4basebio signs clinical supply agreement for Phase II immunotherapy trial opDNA material](https://longbridge.com/en/news/287052696.md)